DataVisor, a stand-out provider of AI-powered fraud and financial crime prevention solutions, has been recognized as a Leader, the report’s highest designation, in the latest evaluation of The ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

Denfy, a globally recognised RegTech company specialising in identity verification, fraud prevention, and compliance ...

ChiefDaily Observer NewspaperMonrovia, LiberiaSubject: Misleading and Inaccurate Reporting on April 10, 2025, Edition -- "ArcelorMittal Defies Liberian Government"Dear Editor-in-Chief,We write on ...

The FDA previously granted breakthrough therapy designation to ziftomenib for relapsed/refractory NPM1-mutant AML.

First AML and Know Your Customer Announce Strategic Partnership First AML, a leading provider of an all-in-one anti-money ...

For decades, the US has served as the world's leading enforcer against financial crime. Trapets executive Joe Biddle examines ...

The decision to stop enforcing the Corporate Transparency Act, which requires the disclosure of the beneficial ownership of ...

Evaluation of market's 15 preeminent AML solutions finds SAS Anti-Money Laundering a great fit for firms that need ...

Block Inc. has reached a $40 million settlement with the New York Department of Financial Services over alleged inadequacies ...

SLS009 is associated with an improvement in survival among patients with relapsed/refractory acute myeloid leukemia.

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...